VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ZEPPZepp Health Corporation
$4.49$4M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksZEPPCash Flow

Zepp Health Corporation (ZEPP) Cash Flow Statement

11Y historyFree accessUpdated daily

Liquidity is under severe pressure as evidenced by a negative free cash flow of $185.1 million in 2025Q4, representing a negative FCF margin of 31.0%.

ZEPP Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15
Cash from Operations-179.65M-24.39M42.6M-117.11M-331.77M150.78M443.55M720.98M229.83M15.28M-6.99M
Operating CF Margin %-9.9%-1.83%1.71%-2.78%-5.38%2.48%7.65%19.04%11.51%0.94%-0.75%
Operating CF Growth %-636.53%-157.26%136.38%64.7%-320.03%-66.01%-38.48%213.71%1404.48%318.69%-
Net Income-280.18M-75.81M-31.09M-43.35M136.02M216.27M573.64M353.31M163.46M25.05M-39.07M
Depreciation & Amortization31.71M5.02M7.69M8.71M51.21M25.65M17.17M6.46M3.62M2.51M294.19K
Stock-Based Compensation17.43M4.78M8.79M7.27M0000000
Deferred Taxes15.65M13.45M-2.88M-9.92M-18.45M-9.87M-27.72M-34.18M-18.49M00
Other Non-Cash Items145.71M20.51M12.21M2.44M119.98M115.18M112.78M139.78M58.16M63.39M57.8M
Working Capital Changes-109.97M7.66M47.88M-82.26M-620.52M-196.44M-232.31M255.61M23.06M-75.67M-26M
Change in Receivables-80.68M404K43.8M3.13M300.79M427.55M-898.56M-21.09M-119.82M2.32M-18.34M
Change in Inventory-154.48M5.55M51.91M27.92M-82.05M-388.27M-431.81M-244.05M-56.16M-108.23M-54.53M
Change in Payables197.86M14.81M-27.82M-135.34M-664.51M-9.23M933.32M370.22M177.06M284.52M169.34M
Cash from Investing10.35M-1.58M7.73M-6.24M-1.06B-195.59M-112.4M-337.51M-37.9M-103.96M-5.07M
Capital Expenditures-3.61M-1.4M-1.6M-1.21M-52.39M-80.15M-46M-71.85M-21M-12.03M-3.01M
CapEx % of Revenue0.2%0.11%0.06%0.03%0.85%1.32%0.79%1.9%1.05%0.74%0.33%
Acquisitions00427K60K35.99M-32.54M142.61K67.53K2.42M04.13K
Investments-----------
Other Investing2.29M1.66M3.25M-2.57M0-445.28K103.46M-108.68M-14.48M-16.81M0
Cash from Financing173.66M477K-41.68M42.37M646.39M531.78M8.83M678.33M22.1M13.27M220.97M
Debt Issued (Net)-51.29M-1.65M-46.98M16.55M654.58M531.78M-36.65M490.41K22.01M13.24M0
Equity Issued (Net)-8.66M-2.28M-2.52M-8.16M-8.19M050.01M677.84M86.76K25.1K-20.1M
Dividends Paid000-6.3M00-4.53M0000
Share Repurchases-8.66M-2.28M-2.52M-8.16M-13.58M00-8.48M00-20.1M
Other Financing233.61M4.4M7.82M40.28M000000241.07M
Net Change in Cash15.37M-29.73M-652K-95.76M-707.46M580.78M327.49M1.06B228.45M-81.96M221.66M
Free Cash Flow-185.14M-25.88M40.92M-118.59M-377.22M71.79M409.37M703.17M208.91M4.53M-9.99M
FCF Margin %-10.2%-1.94%1.64%-2.81%-6.11%1.18%7.06%18.57%10.46%0.28%-1.08%
FCF Growth %-615.31%-163.25%134.51%68.56%-625.48%-82.46%-41.78%236.59%4512.47%145.32%-
FCF per Share-186.28-1.602.69-7.70-22.834.4125.3550.0014.060.30-0.67
FCF Conversion (FCF/Net Income)0.64x0.04x-0.19x0.40x-2.44x0.70x0.77x2.04x1.41x0.61x0.18x
Interest Paid1.24M89K6.26M8.3M0000000
Taxes Paid062K0512K0000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Unsustainable Cash Burn Rate

Earnings Quality and Cash Disconnect

According to the 2025Q4 financial disclosures, Zepp reported a net loss of $77.1 million alongside an operating cash outflow of $179.7 million, resulting in an OCF/NI ratio of 2.33 that highlights a significant disconnect between accounting losses and actual cash depletion during the period.

The substantial gap between net income and operating cash flow suggests that the company's reported losses are being exacerbated by cash-intensive operational requirements. Investors should monitor this divergence, as it implies that the underlying business model is consuming liquidity at a rate that significantly exceeds the accounting impact of its current operating losses.

Negative Free Cash Flow Trajectory

As reported in the most recent quarterly filings, Zepp generated a negative free cash flow of $185.1 million in 2025Q4, representing a negative FCF margin of 31.0% that underscores the company's current inability to self-fund its strategic pivot toward self-branded wearable products.

The trajectory of free cash flow remains deeply negative, indicating that the company is currently reliant on its existing cash reserves to sustain operations. This trend warrants further investigation into whether the current level of cash burn is a temporary byproduct of aggressive market expansion or a structural feature of the company's high-cost R&D and marketing strategy.

Working Capital Drag on Liquidity

Based on the 2025Q4 cash flow statement, Zepp experienced a working capital outflow of $110.0 million, which served as a primary driver for the quarter's total operating cash deficit and suggests potential inefficiencies in inventory management or collection cycles during this period of rapid growth.

The significant negative impact of working capital changes suggests that the company is tying up substantial liquidity in its operational cycle, likely due to inventory buildup or delayed receivables. This development appears to be a major contributor to the company's cash burn, and investors should monitor whether this is a seasonal anomaly or a persistent trend.

SBC and Capitalized Cost Obfuscation

Data from the 2025Q4 report reveals $17.4 million in stock-based compensation, which, when viewed alongside the $185.1 million free cash flow deficit, suggests that the company is utilizing equity-based incentives to preserve cash while simultaneously facing heavy pressure from its core operational cash requirements.

While stock-based compensation provides a non-cash mechanism to manage expenses, it does not mitigate the underlying cash burn driven by operational and working capital needs. The reliance on these adjustments may mask the true economic cost of the company's growth strategy, warranting a cautious interpretation of the company's long-term cash sustainability.

ZEPP — Frequently Asked Questions

Quick answers to the most common questions about buying ZEPP stock.

How much cash does Zepp Health Corporation (ZEPP) generate from operations?

Zepp Health Corporation (ZEPP) generated $-179.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Zepp Health Corporation's free cash flow?

Zepp Health Corporation (ZEPP) reported negative free cash flow of $185.1M in 2025, indicating capital requirements exceeded cash from operations.

What is Zepp Health Corporation's capital expenditure (CapEx)?

Zepp Health Corporation (ZEPP) spent $3.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Zepp Health Corporation distribute cash to shareholders?

In 2025, Zepp Health Corporation (ZEPP) spent $8.7M on share repurchases. This shows the company's commitment to returning capital to its equity investors.